Sinocare Inc. (SHE:300298)
China
· Delayed Price · Currency is CNY 21.77
-0.08 (-0.37%)
Apr 28, 2025, 2:45 PM CST
Sinocare Revenue
In the year 2024, Sinocare had annual revenue of 4.44B CNY with 9.47% growth. Sinocare had revenue of 1.26B in the quarter ending December 31, 2024, with 23.22% growth.
Revenue
4.44B
Revenue Growth
+9.47%
P/S Ratio
2.71
Revenue / Employee
923.92K
Employees
4,531
Market Cap
12.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.44B | 384.34M | 9.47% |
| Dec 31, 2023 | 4.06B | 106.37M | 2.69% |
| Jan 1, 2023 | 3.95B | 1.59B | 67.38% |
| Jan 1, 2022 | 2.36B | 346.09M | 17.17% |
| Dec 31, 2020 | 2.02B | 237.00M | 13.33% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.98B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |